Thermoreversible poly(ethylene glycol)-g-chitosan hydrogel as a therapeutic T lymphocyte depot for localized glioblastoma immunotherapy

Biomacromolecules

Volumn 15, Issue 7, 2014, Pages 2656-2662

  Tsao, Ching Ting ^a   Kievit, Forrest M ^b   Ravanpay, Ali ^b   Erickson, Ariane E ^a   Jensen, Michael C ^c   Ellenbogen, Richard G ^b   Zhang, Miqin ^a,b  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; HYDROGELS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYETHYLENE GLYCOLS;

ANTI-GLIOBLASTOMA; BIODEGRADABLE HYDROGELS; GLIOBLASTOMA CELLS; GLIOBLASTOMAS; LOCALIZED DELIVERY; RHEOLOGICAL STUDIES; SOL-TO-GEL TRANSITION; THERMOREVERSIBLE;

LYMPHOCYTES;

CHITOSAN DERIVATIVE; INTERLEUKIN 15; INTERLEUKIN 2; MACROGOL; MATRIGEL; POLY(ETHYLENE GLYCOL) G CHITOSAN HYDROGEL; UNCLASSIFIED DRUG; CHITOSAN; CULTURE MEDIUM; HYDROGEL; MACROGOL DERIVATIVE;

ARTICLE; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CHEMICAL BINDING; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; MEMORY T LYMPHOCYTE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; T LYMPHOCYTE; ADOPTIVE IMMUNOTHERAPY; ANALOGS AND DERIVATIVES; APOPTOSIS; BRAIN NEOPLASMS; CELL MOTION; CELL SURVIVAL; CHEMISTRY; CULTURE MEDIUM; CYTOTOXICITY; PHYSIOLOGY; TISSUE SCAFFOLD; TRANSITION TEMPERATURE; TUMOR CELL LINE;

APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHITOSAN; CULTURE MEDIA; CYTOTOXICITY, IMMUNOLOGIC; GLIOBLASTOMA; HUMANS; HYDROGELS; IMMUNOTHERAPY, ADOPTIVE; POLYETHYLENE GLYCOLS; T-LYMPHOCYTES; TISSUE SCAFFOLDS; TRANSITION TEMPERATURE;

EID: 84904364053     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm500502n     Document Type: Article

References (27)

1. Florczyk, S. J.; Wang, K.; Jana, S.; Wood, D. L.; Sytsma, S. K.; Sham, J. G.; Kievit, F. M.; Zhang, M. Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM Biomaterials 2013, 34 (38) 10143-50
2. Wang, K.; Park, J. O.; Zhang, M. Treatment of glioblastoma multiforme using a combination of small interfering RNA targeting epidermal growth factor receptor and β-catenin J. Gene Med. 2013, 15 (1) 42-50
3. Westphal, M.; Lamszus, K. The neurobiology of gliomas: From cell biology to the development of therapeutic approaches Nat. Rev. Neurosci. 2011, 12 (9) 495-508
4. Grossman, S. A.; Ye, X.; Piantadosi, S.; Desideri, S.; Nabors, L. B.; Rosenfeld, M.; Fisher, J. Survival of patients with newly diagnosed glioblastoma treated with radiation and Temozolomide in research studies in the United States Clin. Cancer Res. 2010, 16 (8) 2443-9
5. Ulmer, S.; Spalek, K.; Nabavi, A.; Schultka, S.; Mehdorn, H. M.; Kesari, S.; Dorner, L. Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma Neuro-Oncology (Cary, NC, U.S.) 2012, 14 (4) 482-90
6. Westphal, M.; Hilt, D. C.; Bortey, E.; Delavault, P.; Olivares, R.; Warnke, P. C.; Whittle, I. R.; Jaaskelainen, J.; Ram, Z. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Neuro-Oncology (Cary, NC, U.S.) 2003, 5 (2) 79-88
7. Wolinsky, J. B.; Colson, Y. L.; Grinstaff, M. W. Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers J. Controlled Release 2012, 159 (1) 14-26
8. Sawyer, A. J.; Piepmeier, J. M.; Saltzman, W. M. New methods for direct delivery of chemotherapy for treating brain tumors Yale J. Biol. Med. 2006, 79 (3-4) 141-52
9. Kang, Y. M.; Kim, G. H.; Kim, J. I.; Kim da, Y.; Lee, B. N.; Yoon, S. M.; Kim, J. H.; Kim, M. S. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer Biomaterials 2011, 32 (20) 4556-64
10. Sampson, J. H.; Akabani, G.; Archer, G. E.; Berger, M. S.; Coleman, R. E.; Friedman, A. H.; Friedman, H. S.; Greer, K.; Herndon, J. E., II; Kunwar, S.; McLendon, R. E.; Paolino, A.; Petry, N. A.; Provenzale, J. M.; Reardon, D. A.; Wong, T. Z.; Zalutsky, M. R.; Pastan, I.; Bigner, D. D. Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors Neuro-Oncology (Cary, NC, U.S.) 2008, 10 (3) 320-9
11. Rainov, N. G. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme Hum. Gene Ther. 2000, 11 (17) 2389-401
12. Westphal, M.; Giese, A. Local control of gliomas: The next best step-a good step? Front. Radiat. Ther. Oncol. 1999, 33, 214-26
13. Restifo, N. P.; Dudley, M. E.; Rosenberg, S. A. Adoptive immunotherapy for cancer: Harnessing the T cell response Nat. Rev. Immunol. 2012, 12 (4) 269-81
14. Hussain, S. F.; Heimberger, A. B. Immunotherapy for human glioma: Innovative approaches and recent results Expert Rev. Anticancer Ther. 2005, 5 (5) 777-90
15. Kahlon, K. S.; Brown, C.; Cooper, L. J.; Raubitschek, A.; Forman, S. J.; Jensen, M. C. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells Cancer Res. 2004, 64 (24) 9160-6
16. Hudecek, M.; Lupo-Stanghellini, M. T.; Kosasih, P. L.; Sommermeyer, D.; Jensen, M. C.; Rader, C.; Riddell, S. R. Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells Clin. Cancer Res. 2013, 19 (12) 3153-64
17. Tanaka, S.; Louis, D. N.; Curry, W. T.; Batchelor, T. T.; Dietrich, J. Diagnostic and therapeutic avenues for glioblastoma: No longer a dead end? Nat. Rev. Clin. Oncol. 2012, 10 (1) 14-26
18. Chen, S. H.; Tsao, C. T.; Chang, C. H.; Lai, Y. T.; Wu, M. F.; Chuang, C. N.; Chou, H. C.; Wang, C. K.; Hsieh, K. H. Assessment of reinforced poly(ethylene glycol) chitosan hydrogels as dressings in a mouse skin wound defect model Mater. Sci. Eng., C 2013, 33 (5) 2584-94
19. Bhattarai, N.; Matsen, F. A.; Zhang, M. PEG-grafted chitosan as an injectable thermoreversible hydrogel Macromol. Biosci. 2005, 5 (2) 107-11
20. Bhattarai, N.; Ramay, H. R.; Gunn, J.; Matsen, F. A.; Zhang, M. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release J. Controlled Release 2005, 103 (3) 609-24
21. Bhattarai, N.; Gunn, J.; Zhang, M. Chitosan-based hydrogels for controlled, localized drug delivery Adv. Drug Delivery Rev. 2010, 62 (1) 83-99
22. Kurita, K. Chitin and chitosan: Functional biopolymers from marine crustaceans Mar. Biotechnol. 2006, 8 (3) 203-26
23. Chen, S. H.; Tsao, C. T.; Chang, C. H.; Wu, Y. M.; Liu, Z. W.; Lin, C. P.; Wang, C. K.; Hsieh, K. H. Synthesis and characterization of thermal-responsive chitin-based polyurethane copolymer as a smart material Carbohydr. Polym. 2012, 88 (4) 1483-7
24. Zhang, T.; Somasundaram, R.; Berencsi, K.; Caputo, L.; Gimotty, P.; Rani, P.; Guerry, D.; Swoboda, R.; Herlyn, D. Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4 Eur. J. Immunol. 2006, 36 (2) 457-67
25. Spiller, K. L.; Laurencin, S. J.; Charlton, D.; Maher, S. A.; Lowman, A. M. Superporous hydrogels for cartilage repair: Evaluation of the morphological and mechanical properties Acta Biomaterialia 2008, 4 (1) 17-25
26. Sashiwa, H.; Yamamori, N.; Ichinose, Y.; Sunamoto, J.; Aiba, S. Michael reaction of chitosan with various acryl reagents in water Biomacromolecules 2003, 4 (5) 1250-4
27. Schor, S. L.; Allen, T. D.; Winn, B. Lymphocyte migration into three-dimensional collagen matrices: A quantitative study J. Cell Biol. 1983, 96 (4) 1089-96